Showing results (2311-2320 of 2,381) with videos related to

Sort By:
Pageof 239
The Journal of Pathology|April 4, 2022
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatmentAlexander Hennig, Franziska Baenke, Anna Klimova, et al.
Nature Genetics|October 31, 2006
DNA methylation profiling of human chromosomes 6, 20 and 22Florian Eckhardt, Joern Lewin, Rene Cortese, et al.
ESMO Open|May 9, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trialE Livingstone, H J Gogas, L Kandolf, et al.
Nature Physics|December 15, 2025
Cavity electrodynamics of van der Waals heterostructuresGunda Kipp, Hope M Bretscher, Benedikt Schulte, et al.
Trials|June 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Heart Rhythm|April 5, 2020
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart AssociationDhanunjaya R Lakkireddy, Mina K Chung, Rakesh Gopinathannair, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2023
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trialE Livingstone, H Gogas, L Kandolf-Sekulovic, et al.
Trials|November 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
International Journal of Cancer|July 9, 2015
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancerJohn J Arcaroli, W M Tai, Ryan McWilliams, et al.
Trials|June 10, 2020
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Pageof 239